This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
mmu-miR-7031-5pMIMAT0027966 0.0e+0 3.0e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7032-5pMIMAT0027968 0.0e+0 6.5e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7033-5pMIMAT0027970 0.0e+0 1.1e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7036a-5pMIMAT0027976 0.0e+0 8.3e-13Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7040-5pMIMAT0027984 0.0e+0 2.9e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7042-5pMIMAT0027988 0.0e+0 1.2e-10Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7043-5pMIMAT0027990 0.0e+0 3.4e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7044-5pMIMAT0027992 0.0e+0 6.0e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7045-5pMIMAT0027994 0.0e+0 1.2e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7046-5pMIMAT0027996 0.0e+0 5.9e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7047-5pMIMAT0027998 0.0e+0 1.1e-7Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7048-5pMIMAT0028000 0.0e+0 2.1e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-705MIMAT0003495 0.0e+0 7.6e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available13 / 0 / 13
mmu-miR-7050-5pMIMAT0028004 0.0e+0 8.3e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7056-5pMIMAT0028016 0.0e+0 5.5e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7058-5pMIMAT0028020 0.0e+0 5.0e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7070-5pMIMAT0028046 0.0e+0 3.5e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7082-5pMIMAT0028070 0.0e+0 5.6e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7085-5pMIMAT0028076 0.0e+0 3.7e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7088-5pMIMAT0028082 0.0e+0 3.4e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-709MIMAT0003499 0.0e+0 3.9e-10Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available25 / 0 / 25
mmu-miR-710MIMAT0003500 0.0e+0 2.2e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available3 / 0 / 3
mmu-miR-711MIMAT0003501 0.0e+0 9.2e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000748_131 / 0 / 31
mmu-miR-7118-5pMIMAT0028133 0.0e+0 1.9e-5Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-712-5pMIMAT0003502 0.0e+0 2.0e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available3 / 0 / 3
mmu-miR-714MIMAT0003505 0.0e+0 4.0e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available8 / 0 / 8
mmu-miR-721MIMAT0003515 0.0e+0 2.9e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available4 / 0 / 4
mmu-miR-7216-5pMIMAT0028400 0.0e+0 9.0e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7219-5pMIMAT0028406 0.0e+0 3.4e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7221-3pMIMAT0028411 0.0e+0 1.2e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7222-3pMIMAT0028413 0.0e+0 2.4e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7226-5pMIMAT0028420 0.0e+0 2.0e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7235-5pMIMAT0028438 0.0e+0 4.4e-3Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7241-3pMIMAT0028451 0.0e+0 5.6e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-762MIMAT0003892 0.0e+0 1.3e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000624_160 / 0 / 60
mmu-miR-7647-3pMIMAT0029797 0.0e+0 3.3e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7653-5pMIMAT0029812 0.0e+0 1.1e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7658-5pMIMAT0029822 0.0e+0 4.9e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7672-5pMIMAT0029850 0.0e+0 4.3e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7682-3pMIMAT0029885 0.0e+0 1.8e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7684-3pMIMAT0029891 0.0e+0 2.1e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available1 / 0 / 1
mmu-miR-7686-5pMIMAT0029898 0.0e+0 9.6e-5Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available2 / 0 / 2
mmu-miR-7a-5pMIMAT0000677 0.0e+0 2.6e-8Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000022_120 / 0 / 20
mmu-miR-7b-5pMIMAT0000678 0.0e+0 4.8e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000022_120 / 0 / 20
mmu-miR-8090MIMAT0031391 0.0e+0 4.7e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available9 / 0 / 9
mmu-miR-8094MIMAT0031395 0.0e+0 4.8e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available9 / 0 / 9
mmu-miR-8099MIMAT0031401 0.0e+0 1.3e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0001731_12 / 0 / 2
mmu-miR-8100MIMAT0031403 0.0e+0 2.9e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available13 / 0 / 13
mmu-miR-8101MIMAT0031405 0.0e+0 6.8e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available13 / 0 / 13
mmu-miR-8102MIMAT0031406 0.0e+0 1.6e-4Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available11 / 0 / 11
mmu-miR-8107MIMAT0031412 0.0e+0 4.3e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available7 / 0 / 7
mmu-miR-8110MIMAT0031416 0.0e+0 3.9e-12Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available11 / 0 / 11
mmu-miR-8113MIMAT0031419 0.0e+0 2.5e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available8 / 0 / 8
mmu-miR-8117MIMAT0031423 0.0e+0 7.9e-10Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		Not available11 / 0 / 11
mmu-miR-872-5pMIMAT0004934 0.0e+0 3.0e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000399_16 / 0 / 6
mmu-miR-9-3pMIMAT0000143 0.0e+0 2.8e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000014_225 / 0 / 25
mmu-miR-92a-3pMIMAT0000539 0.0e+0 2.4e-12Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000013_273 / 0 / 73
mmu-miR-93-5pMIMAT0000540 0.0e+0 4.9e-8Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000001_199 / 0 / 99
mmu-miR-96-5pMIMAT0000541 0.0e+0 8.6e-11Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000072_121 / 0 / 21
mmu-miR-99b-5pMIMAT0000132 0.0e+0 6.2e-2Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000033_191 / 0 / 91
hsa-miR-16-5pMIMAT0000069 0.0e+0 9.9e-2Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000006_1113 / 0 / 113
hsa-miR-25-3pMIMAT0000081 0.0e+0 1.6e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000013_273 / 0 / 73
hsa-miR-302d-3pMIMAT0000718 0.0e+0 8.7e-2Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000071_228 / 0 / 28
hsa-miR-378eMIMAT0018927 0.0e+0 1.3e-2Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000168_139 / 0 / 39
hsa-miR-451aMIMAT0001631 0.0e+0 1.3e-2Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000148_1104 / 0 / 104
hsa-miR-579-3pMIMAT0003244 0.0e+0 1.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000317_230 / 0 / 30
hsa-miR-570-3pMIMAT0003235 3.3e-16 1.8e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000317_230 / 0 / 30
hsa-miR-574-5pMIMAT0004795 1.5e-15 1.9e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000419_153 / 0 / 53
hsa-miR-631MIMAT0003300 2.7e-15 1.9e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000508_123 / 0 / 23
hsa-miR-338-3pMIMAT0000763 1.1e-12 2.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000097_220 / 0 / 20
hsa-miR-188-5pMIMAT0000457 1.9e-12 2.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000113_177 / 0 / 77
hsa-miR-489-3pMIMAT0002805 5.1e-12 2.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000111_216 / 0 / 16
hsa-miR-2682-5pMIMAT0013517 2.0e-11 2.4e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		Not available3 / 0 / 3
hsa-miR-222-3pMIMAT0000279 1.1e-10 2.6e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000051_251 / 0 / 51
hsa-miR-371a-3pMIMAT0000723 2.8e-10 2.6e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000068_224 / 0 / 24
hsa-miR-548d-3pMIMAT0003323 6.5e-10 2.7e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000317_230 / 0 / 30
hsa-miR-376a-3pMIMAT0000729 6.9e-10 2.7e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000091_224 / 0 / 24
hsa-miR-888-5pMIMAT0004916 1.2e-9 2.7e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000386_133 / 0 / 33
hsa-miR-612MIMAT0003280 1.5e-9 2.7e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000464_14 / 0 / 4
hsa-miR-149-5pMIMAT0000450 6.2e-9 2.9e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000274_133 / 0 / 33
hsa-miR-2116-5pMIMAT0011160 1.2e-8 2.9e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		Not available10 / 0 / 10
hsa-miR-10a-5pMIMAT0000253 1.6e-8 2.9e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000033_191 / 0 / 91
hsa-miR-361-3pMIMAT0004682 1.6e-8 2.9e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000172_217 / 0 / 17
hsa-miR-223-3pMIMAT0000280 4.4e-8 3.0e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000067_252 / 0 / 52
hsa-let-7a-5pMIMAT0000062 7.9e-8 3.1e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000002_1115 / 0 / 115
hsa-miR-142-3pMIMAT0000434 1.3e-7 3.1e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000084_239 / 0 / 39
hsa-miR-598-3pMIMAT0003266 2.5e-7 3.2e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000393_217 / 0 / 17
hsa-miR-548aiMIMAT0018989 2.7e-7 3.2e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000317_143 / 0 / 43
hsa-miR-302b-3pMIMAT0000715 4.1e-7 3.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000071_228 / 0 / 28
hsa-miR-192-5pMIMAT0000222 4.5e-7 3.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000063_155 / 0 / 55
hsa-miR-548aaMIMAT0018447 7.2e-7 3.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000317_143 / 0 / 43
hsa-miR-514b-5pMIMAT0015087 7.7e-7 3.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000130_165 / 0 / 65
hsa-miR-590-5pMIMAT0003258 8.4e-7 3.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000418_116 / 0 / 16
hsa-miR-4454MIMAT0018976 9.9e-7 3.3e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		Not available31 / 0 / 31
hsa-miR-30e-5pMIMAT0000692 2.4e-6 3.4e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000005_189 / 0 / 89
hsa-miR-297MIMAT0004450 2.4e-6 3.4e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000204_120 / 0 / 20
hsa-miR-1252-5pMIMAT0005944 2.5e-6 3.4e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000968_13 / 0 / 3
hsa-miR-1257MIMAT0005908 3.5e-6 3.5e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000998_16 / 0 / 6
hsa-miR-3614-5pMIMAT0017992 3.6e-6 3.5e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		Not available5 / 0 / 5
hsa-miR-95-3pMIMAT0000094 5.0e-6 3.5e-1Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.		MIPF0000098_229 / 0 / 29
< [583] [584] [585] [586] [587] [588] [589] [590] [591] [592] >